Gerot Lannach was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and has a history of more than 70 years.
We develop, produce and market unique brand name products as well as off-patent products for the wellbeing of people in Austria and abroad. As a supplier to the healthcare sector, we partner with general practitioners, pharmacists, their patients and pharmaceutical wholesalers. As an international player, we market our products through our licensees and branch offices in more than 50 countries.
Our core competence concentrates on three different business areas:
Markets
Our products can be found in more than 50 markets worldwide. Gerot Lannach has 16 distribution structures in Europe and a subsidiary in Central America.
Headcount
~1.000 employees
Revenues
~€220 M. (2021), revenue including Genericon Pharma €320 M. (2021)
Production Volume
~4.400 M. single doses
In healthcare, trust is required.
Gerot Lannach works closely with physicians, other healthcare professionals and medical facilities to provide an optimum patient care.
As a responsible company, Gerot Lannach is committed to transparency.
Within the EFPIA Transparency Code, we disclose financial contributions to healthcare professionals.
